Are there Any Clinical Trials Targeting the STING Pathway?
Yes, several clinical trials are currently investigating the use of STING agonists in cancer therapy. These trials are exploring the efficacy of STING activation in various types of cancer, including melanoma, non-small cell lung cancer, and colorectal cancer. The results from these trials will provide valuable insights into the potential and limitations of STING-targeted therapies.
